XML 69 R60.htm IDEA: XBRL DOCUMENT v3.24.3
Share-based Compensation - Restricted Stock Units Activity Under 2023 Incentive Award Plan (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 2 Months Ended 3 Months Ended 7 Months Ended 9 Months Ended
Jul. 21, 2023
Sep. 30, 2023
Sep. 30, 2024
Jul. 21, 2023
Sep. 30, 2024
Other than options, Weighted Average Exercise Price          
Share-based compensation expense $ 700 $ 2,200 $ 1,600 $ 3,200 $ 4,900
RSU | AEON Biopharma Inc 2023 Incentive Award Plan          
Other than options, Number of Shares          
Granted         1,023,023
Outstanding, ending of period     1,023,023   1,023,023
Other than options, Weighted Average Exercise Price          
Granted         $ 0.83
Outstanding, ending of period     $ 0.83   $ 0.83
Share-based compensation expense     $ 36   $ 36
Unrecognized compensation expense related to other than options     $ 800   $ 800
Weighted-average remaining requisite service period for which unrecognized compensation expense         23 months